Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury

References

• Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346(16):1221–31. doi: 10.1056/NEJMra011775
   PubMed Web of Science ®Google Scholar
• Medina J, Fernandez-Salazar LI, Garcia-Buey L, Moreno-Otero R. Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis. Diabetes Care 2004;27(8):2057–66. doi: 10.2337/diacare.27.8.2057
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102(12):2708–15. doi: 10.1111/j.1572-0241.2007.01526.x
   PubMed Web of Science ®Google Scholar
• Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28(1):27–38. doi: 10.1161/ATVBAHA.107.147538
   PubMed Web of Science ®Google Scholar
• Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363(14):1341–50. doi: 10.1056/NEJMra0912063
   PubMed Web of Science ®Google Scholar
• Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30(1):10–22. doi: 10.2164/jandrol.108.005215
   PubMedGoogle Scholar
• Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011;25(2):337–53. doi: 10.1016/j.beem.2010.07.002
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 2005;90(2):712–9. doi: 10.1210/jc.2004-0970
   PubMed Web of Science ®Google Scholar
• Travison TG, Araujo AB, Kupelian V, O'Donnell AB, McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 2007;92(2):549–55. doi: 10.1210/jc.2006-1859
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 2004;27(5):1036–41. doi: 10.2337/diacare.27.5.1036
   PubMed Web of Science ®Google Scholar
• Kim S, Kwon H, Park JH, Cho B, Kim D, Oh SW, et al. A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. BMC Gastroenterol 2012;12:69. doi: 10.1186/1471-230X-12-69
   PubMed Web of Science ®Google Scholar
• Kostovski E, Iversen PO, Birkeland K, Torjesen PA, Hjeltnes N. Decreased levels of testosterone and gonadotrophins in men with long-standing tetraplegia. Spinal Cord 2008;46(8):559–64. doi: 10.1038/sc.2008.3
   PubMed Web of Science ®Google Scholar
• Durga A, Sepahpanah F, Regozzi M, Hastings J, Crane DA. Prevalence of testosterone deficiency after spinal cord injury. PM R 2011;3(10):929–32. doi: 10.1016/j.pmrj.2011.07.008
   PubMedGoogle Scholar
• Bauman WA, Fountaine MF, Spungen AM. Age-related prevalence of low testosterone in men with spinal cord injury. J Spinal Cord Med 2014;37(1):32–9. doi: 10.1179/2045772313Y.0000000122
   PubMed Web of Science ®Google Scholar
• Barbonetti A, Vassallo MRC, Pacca F, Cavallo F, Costanzo M, Felzani G, et al. Correlates of low testosterone in men with chronic spinal cord injury. Andrology 2014;2(5):721–8. doi: 10.1111/j.2047-2927.2014.00235.x
   PubMed Web of Science ®Google Scholar
• Bauman WA, Spungen AM. Carbohydrate and lipid metabolism in chronic spinal cord injury. J Spinal Cord Med 2001;24(4):266–77.
   PubMedGoogle Scholar
• Jones LM, Legge M, Goulding A. Healthy body mass index (BMI) values often underestimate body fat in spinal cord injured males. Arch Phys Med Rehabil 2003;84(7):1068–71. doi: 10.1016/S0003-9993(03)00045-5
   PubMed Web of Science ®Google Scholar
• Maynard FM Jr, Bracken MB, Creasey G, Ditunno JF Jr, Donovan WH, Ducker TB, et al. International standards for neurological and functional classification of spinal cord injury. Spinal Cord 1997;35(5):266–74. doi: 10.1038/sj.sc.3100432
   PubMed Web of Science ®Google Scholar
• Catz A, Itzkovich M, Agranov E, Ring H, Tamir A. SCIM–spinal cord independence measure: a new disability scale for patients with spinal cord lesions. Spinal Cord, 1997;35(12):850–6. doi: 10.1038/sj.sc.3100504
   PubMed Web of Science ®Google Scholar
• Martin Ginis KA, Phang SH, Latimer AE, Arbour-Nicitopoulos KP. Reliability and validity tests of the leisure time physical activity questionnaire for people with spinal cord injury. Arch Phys Med Rehabil 2012;93(4):677–82. doi: 10.1016/j.apmr.2011.11.005
   PubMed Web of Science ®Google Scholar
• Ginis KA, Hicks AL, Latimer AE, Warburton DE, Bourne C, Ditor DS, et al. The development of evidence-informed physical activity guidelines for adults with spinal cord injury. Spinal Cord 2011;49(11):1088–96. doi: 10.1038/sc.2011.63
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84(10):3666–72. doi: 10.1210/jcem.84.10.6079
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412–9. doi: 10.1007/BF00280883
   PubMed Web of Science ®Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, et al. Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010;95(6):2536–59. doi: 10.1210/jc.2009-2354
   PubMed Web of Science ®Google Scholar
• Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 2006;147(1):141–54. doi: 10.1210/en.2004-1649
   PubMed Web of Science ®Google Scholar
• Ramirez ME, McMurry MP, Wiebke GA, Felten KJ, Ren K, Meikle AW, et al. Evidence for sex steroid inhibition of lipoprotein lipase in men: comparison of abdominal and femoral adipose tissue. Metabolism 1997;46(2):179–85. doi: 10.1016/S0026-0495(97)90299-7
   PubMed Web of Science ®Google Scholar
• Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006;154(6):899–906. doi: 10.1530/eje.1.02166
   PubMed Web of Science ®Google Scholar
• Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight los and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004;6(3):208–15. doi: 10.1111/j.1462-8902.2004.00335.x
   PubMed Web of Science ®Google Scholar
• Buchholz AC, McGillivray CF, Pencharz PB. Differences in resting metabolic rate between paraplegic and able-bodied subjects are explained by differences in body composition. Am J Clin Nutr 2003;77(2):371–8.
   PubMed Web of Science ®Google Scholar
• Latimer AE, Ginis KA, Craven BC, Hicks AL. The physical activity recall assessment for people with spinal cord injury: validity. Med Sci Sports Exerc 2006;38(2):208–16. doi: 10.1249/01.mss.0000183851.94261.d2
   PubMed Web of Science ®Google Scholar
• Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, et al. Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor. Hepatology 2008;47(6):1924–35. doi: 10.1002/hep.22252
   PubMed Web of Science ®Google Scholar
• Dowman JK, Hopkins LJ, Reynolds GM, Armstrong MJ, Nasiri M, Nikolaou N, et al. Loss of 5a-reductase Type 1 accelerates the development of hepatic steatosis but protects against hepatocellular carcinoma in male mice. Endocrinology 2013;154(12):4536–47. doi: 10.1210/en.2013-1592
   PubMed Web of Science ®Google Scholar
• Zhang H, Liu Y, Wang L, Li Z, Zhang H, Wu J, et al. Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. J Lipid Res 2013;54(2):345–57. doi: 10.1194/jlr.M028969
   PubMed Web of Science ®Google Scholar
• Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15(5):539–43.
   PubMed Web of Science ®Google Scholar
• Nikolaenko L, Jia Y, Wang C, Diaz-Arjonilla M, Yee JK, French SW, et al. Testosterone replacement ameliorates nonalcoholic fatty liver disease in castrated male rats. Endocrinology 2014;155(2):417–28. doi: 10.1210/en.2013-1648
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Filippi S, Comeglio P, Cellai I, Sarchielli E, Morelli A, et al.. Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: An experimental study in the rabbit. Mol Cell Endocrinol 2014;384(1–2):143–54. doi: 10.1016/j.mce.2014.01.014
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Morelli A, Sarchielli E, Comeglio P, Filippi S, et al. Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit. J Endocrinol 2012;212(1):71–84. doi: 10.1530/JOE-11-0289
   PubMed Web of Science ®Google Scholar
• Hoyos CM, Yee BJ, Phillips CL, Machan EA, Grunstein RR, Liu PY. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnea: a randomized placebo-controlled trial. Eur J Endocrinol 2012;167(4):531–41. doi: 10.1530/EJE-12-0525
   PubMed Web of Science ®Google Scholar
• Huang G, Bhasin S, Tang ER, Aakil A, Anderson SW, Jara H, et al. Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial. J Gerontol A Biol Sci Med Sci 2013;68(8):954–9. doi: 10.1093/gerona/gls259
   PubMed Web of Science ®Google Scholar